Cargando…

An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma

OBJECTIVES: The objective of this study was to explore the association between health-related quality of life (HRQoL) and the recommended phase 2 dose in a phase I clinical trial according to the Time to HRQoL deterioration approach (TTD). SETTING: This is a phase I dose-escalation trial of transart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anota, Amélie, Boulin, Mathieu, Dabakuyo-Yonli, Sandrine, Hillon, Patrick, Cercueil, Jean-Pierre, Minello, Anne, Jouve, Jean-Louis, Paoletti, Xavier, Bedenne, Laurent, Guiu, Boris, Bonnetain, Franck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932346/ https://www.ncbi.nlm.nih.gov/pubmed/27342239 http://dx.doi.org/10.1136/bmjopen-2015-010696

Ejemplares similares

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
por: Guiu, Boris, et al.
Publicado: (2019)

Health-related quality of life as an endpoint in oncology phase I trials: a systematic review
por: Fiteni, Frédéric, et al.
Publicado: (2019)

Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial
por: Rotonda, Christine, et al.
Publicado: (2015)

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists
por: Methy, Nicolas, et al.
Publicado: (2010)

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
por: Golfieri, R, et al.
Publicado: (2014)

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
por: Nyman, Sofi Sennefelt, et al.
Publicado: (2022)

Is Chemoembolisation of Value in Inoperable Primary Hepatocellular Carcinoma
por: Raoul, Jean-Luc
Publicado: (1998)

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial
por: Mamguem Kamga, Ariane, et al.
Publicado: (2020)

Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial
por: Pozet, Astrid, et al.
Publicado: (2016)

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma
por: Chehimi, Mohamad, et al.
Publicado: (2016)

Transarterial chemoembolisation of colorectal liver metastases with irinotecan-loaded beads: What every interventional radiologist should know
por: Iezzi, Roberto, et al.
Publicado: (2020)

A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
por: Shi, Xiaonan, et al.
Publicado: (2023)

Optimized Loading of Idarubicin in CalliSpheres(®) Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties
por: Lu, Enhao, et al.
Publicado: (2021)

Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours
por: Marrache, F, et al.
Publicado: (2007)

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report
por: Martin, Robert CG, et al.
Publicado: (2009)

PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL
por: Wasse, Stephane, et al.
Publicado: (2023)

Confocal microscopy of idarubicin localisation.
por: Manfait, M., et al.
Publicado: (1997)

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients
por: Pozet, Astrid, et al.
Publicado: (2023)

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
por: Billa, Oumar, et al.
Publicado: (2021)

Impact of Response Shift on Time to Deterioration in Quality of Life Scores in Breast Cancer Patients
por: Hamidou, Zeinab, et al.
Publicado: (2014)

Confocal microscopy of idarubicin localisation - reply
por: Duffy, P, et al.
Publicado: (1997)

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial
por: Anota, Amélie, et al.
Publicado: (2015)

Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study
por: Anota, Amélie, et al.
Publicado: (2014)

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
por: Boddu, Prajwal, et al.
Publicado: (2018)

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer
por: Mamguem Kamga, Ariane, et al.
Publicado: (2021)

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
por: Ousmen, Ahmad, et al.
Publicado: (2018)

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
por: Meyer, T, et al.
Publicado: (2013)

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
por: Dahan, Laetitia, et al.
Publicado: (2010)

Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma
por: Paquette, Brice, et al.
Publicado: (2016)

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
por: Schlenk, R. F., et al.
Publicado: (2019)

Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
por: Sierra, Jorge, et al.
Publicado: (2023)

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
por: Charton, Emilie, et al.
Publicado: (2019)

Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)
por: Servagi-Vernat, Stéphanie, et al.
Publicado: (2017)

Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time
por: Ousmen, Ahmad, et al.
Publicado: (2016)

Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
por: Perfahl, H., et al.
Publicado: (2020)

Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study
por: Auguste, Aviane, et al.
Publicado: (2017)

High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial
por: Li, Jun, et al.
Publicado: (2022)

Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients
por: Anota, Amélie, et al.
Publicado: (2014)

Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE)
por: Peisen, Felix, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5nipmopl8e7017oqorbss40rq